<DOC>
	<DOCNO>NCT01122485</DOCNO>
	<brief_summary>The objective study explore efficacy , dose-response safety PG201 tablet Korean patient osteoarthritis .</brief_summary>
	<brief_title>Efficacy Safety Study PG201 Tablet Patients With Osteoarthritis</brief_title>
	<detailed_description>In study , PG201 extract , study drug , administer twice daily meal two investigational group , lower-dose group higher-dose group . The efficacy dose group compare control group determine statistically significant difference investigational group placebo group . In addition , efficacy lower dose group high dose group also compare determine statistically significant difference .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Patients ≥40 ≤ 75 year age For woman , meet one follow criterion eligible study : ) A woman childbearing potential ii ) As woman childbearing potential , negative pregnancy test result screen baseline/randomization Patients able willing provide write informed consent . Patients able read understand information provide study able record information request study . Patients meet American College Rheumatology clinical plus radiographic classification criterion idiopathic osteoarthritis knee , define follow : patient knee pain radiographically diagnose osteophyte meet least one following . ) Age &gt; 50 year ii ) Morning stiffness le 30 minute iii ) Crepitus movement weightbearing knee Patients symptomatic primary osteoarthritis knee least last 3 month prior screen . Patients severity grade 2 3 accord Kellgren &amp; Lawrence scale base anteroposterior radiographic evidence tibiofemoral joint osteoarthritis , classify functional class I , II III accord American Rheumatism Association functional classification . Patients score Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) pain subscale question 1 ≤80 mm screening , score Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) pain subscale question 1 ≥50 mm baseline . decrease score Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) pain subscale question 1 least 15mm screen baseline decrease patient selfassessed arthritis symptom score least one point screen baseline . Patients receive Nonsteroidal antiinflammatory drug ( NSAIDs ) /Cyclooxygenase2 inhibitor treatment arthritis knee least 5 day week 4 week prior screen Patients know hypersensitivity intolerance Nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin Cyclooxygenase2 inhibitor . Patients clinical biochemical abnormal finding ( exclude find related investigate disease ) screen visit , investigator 's opinion consider clinically significant might make safe participation study difficult Patients history gastroduodenal perforation and/or occlusion , gastric duodenal surgery , progressive upper gastrointestinal ulcer within last 6 month history upper gastrointestinal bleeding ( include hematemesis ) within last one year , low gastrointestinal bleeding within last one year ( exclude hemorrhoid ) , inflammatory intestinal disease within last 6 month , coronary artery disease , congestive heart failure renal artery stenosis , stroke transient ischemic attack . Patients uncontrollable hypertension Patients receive aspirin therapy ( lowdose aspirin daily dose 325mg less permitted prevention cardiovascular disease ) . Patients receive anticoagulant drug antiplatelet drug ( exclude lowdose aspirin ) disease associate hemostatic disorder . Patients creatinine , bilirubin , Alanine aminotransferase Aspartate aminotransferase &gt; 1.5 time Upper Lange normal screening . Patients two bilirubin , Alanine aminotransferase Aspartate aminotransferase level great Upper Lange normal also exclude . Patients history drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>